Enfusion Performance
| ENFNDelisted Stock | USD 10.76 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0222, which means not very significant fluctuations relative to the market. As returns on the market increase, Enfusion's returns are expected to increase less than the market. However, during the bear market, the loss of holding Enfusion is expected to be smaller as well. Enfusion right now shows a risk of 0.0%. Please confirm Enfusion potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if Enfusion will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Enfusion has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Enfusion is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
Enfusion |
Enfusion Relative Risk vs. Return Landscape
If you would invest 1,076 in Enfusion on October 28, 2025 and sell it today you would earn a total of 0.00 from holding Enfusion or generate 0.0% return on investment over 90 days. Enfusion is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Enfusion, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Enfusion Target Price Odds to finish over Current Price
The tendency of Enfusion Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 10.76 | 90 days | 10.76 | over 95.54 |
Based on a normal probability distribution, the odds of Enfusion to move above the current price in 90 days from now is over 95.54 (This Enfusion probability density function shows the probability of Enfusion Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Enfusion has a beta of 0.0222 suggesting as returns on the market go up, Enfusion average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Enfusion will be expected to be much smaller as well. Additionally Enfusion has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Enfusion Price Density |
| Price |
Predictive Modules for Enfusion
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Enfusion. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Enfusion Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Enfusion is not an exception. The market had few large corrections towards the Enfusion's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Enfusion, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Enfusion within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.01 | |
β | Beta against Dow Jones | 0.02 | |
σ | Overall volatility | 0.20 | |
Ir | Information ratio | -0.08 |
Enfusion Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Enfusion for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Enfusion can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Enfusion is not yet fully synchronised with the market data | |
| Enfusion has a very high chance of going through financial distress in the upcoming years | |
| Over 96.0% of the company shares are held by institutions such as insurance companies |
Enfusion Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Enfusion Stock often depends not only on the future outlook of the current and potential Enfusion's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enfusion's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 129.6 M | |
| Cash And Short Term Investments | 54.5 M |
Enfusion Fundamentals Growth
Enfusion Stock prices reflect investors' perceptions of the future prospects and financial health of Enfusion, and Enfusion fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Enfusion Stock performance.
| Return On Equity | 0.0442 | |||
| Return On Asset | 0.0305 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 1.01 B | |||
| Shares Outstanding | 94.8 M | |||
| Price To Earning | 0.11 X | |||
| Price To Book | 13.93 X | |||
| Price To Sales | 5.06 X | |||
| Revenue | 201.61 M | |||
| EBITDA | 6.16 M | |||
| Cash And Equivalents | 56.56 M | |||
| Cash Per Share | 0.84 X | |||
| Total Debt | 20.31 M | |||
| Book Value Per Share | 0.77 X | |||
| Cash Flow From Operations | 34.68 M | |||
| Earnings Per Share | 0.03 X | |||
| Total Asset | 143.26 M | |||
| Retained Earnings | (170.11 M) | |||
About Enfusion Performance
By examining Enfusion's fundamental ratios, stakeholders can obtain critical insights into Enfusion's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Enfusion is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois. Enfusion Inc operates under SoftwareApplication classification in the United States and is traded on New York Stock Exchange. It employs 892 people.Things to note about Enfusion performance evaluation
Checking the ongoing alerts about Enfusion for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Enfusion help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Enfusion is not yet fully synchronised with the market data | |
| Enfusion has a very high chance of going through financial distress in the upcoming years | |
| Over 96.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Enfusion's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Enfusion's stock is overvalued or undervalued compared to its peers.
- Examining Enfusion's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Enfusion's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Enfusion's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Enfusion's stock. These opinions can provide insight into Enfusion's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Enfusion Stock
If you are still planning to invest in Enfusion check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enfusion's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |